Related Experiment Videos
[Rapid screening of the Duchenne muscular dystrophy gene deletion by two multiplex PCR]
S Ma1
1Institute of Basic Medical Sciences, Beijing.
Abstract:
Duchenne muscular dystrophy (DMD) is one of the most common lethal X-linked disorders. Partial intragenic deletions account for up to 60% of DMD deletions, and approximately one-third of all cases arise via new mutations. In this paper, two sets of primers were used for two multiplex PCR screenings of DMD gene deletions. The first set consists of 5 pairs of primers which amplify 5 exons with higher deletion frequencies, and the second set includes other 4 pairs of primers. Fifty-one DMD samples were screened by the first set, and then those not found to have deletions were screened by the second set. In total, 25 deletions were identified in the Fifty-one DMD samples: That is, about 49% of all cases studied were found to have deletions.
Insights
This study screened 51 Duchenne muscular dystrophy (DMD) samples for gene deletions using multiplex PCR. Approximately 49% of DMD cases studied had deletions, highlighting the importance of PCR screening for genetic disorders.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Context:
- Duchenne muscular dystrophy (DMD) is a frequent and fatal X-linked genetic disorder.
- Partial intragenic deletions are responsible for up to 60% of DMD deletions.
- New mutations account for about one-third of all DMD cases.
Purpose:
- To screen for deletions in the Duchenne muscular dystrophy gene using multiplex PCR.
- To identify the frequency of DMD gene deletions in a cohort of patients.
Summary:
- Two sets of multiplex PCR primers were employed to screen 51 DMD samples.
- The first set amplified 5 exons with high deletion frequencies, followed by a second set of 4 primers for remaining samples.
- Multiplex PCR identified deletions in 25 out of 51 DMD samples, indicating a 49% detection rate.
Impact:
- This study demonstrates the effectiveness of multiplex PCR in detecting DMD gene deletions.
- The findings contribute to understanding the genetic basis of Duchenne muscular dystrophy.
- Early and accurate genetic diagnosis is crucial for managing DMD patients.